Zobrazeno 1 - 6
of 6
pro vyhledávání: '"John, Nacey"'
Autor:
Ellie-May Jarvis, Shaun Collings, Astrid Authier-Hall, Nathaniel Dasyam, Brendan Luey, John Nacey, Gavin F. Painter, Brett Delahunt, Ian F. Hermans, Robert Weinkove
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Prostate cancer is the second most common cancer in men worldwide. Despite an abundance of prostate-specific antigens, immunotherapies have yet to become a standard of care, potentially limited by T-cell dysfunction. Up to 10% of human circulating T-
Externí odkaz:
https://doaj.org/article/d726908ea6fa4815a7d301e76cd6be96
Autor:
Ciléin Kearns, Samantha Murton, Karen Oldfield, Augustus Anderson, Allie Eathorne, Richard Beasley, John Nacey, Chrystal Jaye
Publikováno v:
Journal of visual communication in medicine. 45(4)
Drawing has played a key role in the development and dissemination of Medicine and Surgery, such as to share anatomy, pathology, and techniques for clinical interventions. While many of the visuals used in medicine today are created by medical illust
Autor:
John, Nacey, Brett, Delahunt, Stephen, Mark, John, Matthews, Andrew, Williams, Trish, White, Andrew, Simpson
Publikováno v:
The New Zealand medical journal. 128(1420)
Publikováno v:
The New Zealand medical journal. 126(1381)
Prostate cancer is the second most common cancer among men in New Zealand. Prostate-specific antigen (PSA) as a screening tool for prostate cancer remains controversial. The aim was to determine the rate of PSA screening in New Zealand and to survey
Autor:
David S, Lamb, Olivia, Bupha-Intr, Peter, Bethwaite, Judy, Murray, John, Nacey, Grant, Russell, Brett, Delahunt
Publikováno v:
Anticancer research. 28(6B)
This study, investigating ethnic differences in the diagnosis and treatment of prostate cancer, was performed because of a perceived paucity of Măori men receiving treatment for localised prostate cancer in the greater Wellington region. It was cons
Publikováno v:
The New Zealand medical journal. 118(1209)
To predict differences in prostate cancer rates between New Zealand's major ethnic groups using community-based levels of elevated serum prostate-specific antigen (PSA).This study was undertaken in the Wellington region of New Zealand. 1425 subjects